FDA Investigating Delaware Heparin Deaths
The Food and Drug Administration is investigating the death of two Delaware hospital patients who were given the blood thinner heparin.
Officials at Beebe Medical Center in Lewes said three patients suffered adverse reactions after being given the drug last week. Two of the patients, a 71-year-old man and a 64-year-old woman, died over the weekend.
An FDA spokeswoman said the agency is working with the hospital and Baxter Healthcare Corp., provider of the drug, to determine what happened.
Copyright 2024 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Popular Today
- Beyond the Claim: How Social Canvassing is Transforming Insurance Fraud Detection
- Jury Awards $80M to 3 Former Zurich NA Employees for Wrongful Termination
- DraftKings Sued Over ‘Risk-Free’ Bets That Were Anything But
- California Sees Two More Property Insurers Withdraw From Market
Popular This Month